GGrantIndex
Sort

8,912 grants matching sars cov 2

COVID-19: Identification and Development of Clinical Candidates to Treat SARS-CoV-2

$125,000
Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR

The role of the microbiome in childhood disease

$124,965
Suchitra Hourigan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

SARS-CoV2 sequencing surveillance program for Upstate South Carolina

$124,952
Hai Yao · Clemson University · P20 · FY2021 · GM

Collaborative Research: RAPID: Molecular underpinnings that define volatile compound signature of the lung

$124,887
Abhinav Bhushan · Illinois Institute Of Technology · · FY2020 · BIO

Research Supplement to Promote Diversity for R01GM145700

$124,874
Bin Chen · Michigan State University · R01 · FY2024 · GM

In Silico Screening for Cancer Targets

$124,554
Marc Nicklaus · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA

RAPID: Immunogenicity of SARS-CoV2 to Human T Cells

$124,472
Arup K Chakraborty · Massachusetts Institute Of Technology · · FY2020 · MPS

Tulane National Primate Research Center Emergency Response to COVID-19 Expansion of Outdoor Breeding Corrals

$124,450
Lee Hamm · Tulane University Of Louisiana · P51 · FY2021 · OD

Phenotypic and functional characterization of Betacoronavirus Internal protein in relation to virulence

$124,281
Lok-Yin Roy Wong · University Of Iowa · K99 · FY2022 · AI

Administrative Core

$123,969
John P. Kirwan · Lsu Pennington Biomedical Research Ctr · U54 · FY2022 · GM

Computational mapping of human B cell migration and differentiation pathways

$123,846
Kenneth Hoehn · Yale University · K99 · FY2022 · AI

RAPID: Determination of health risks and Status from SARS-CoV-2 Presence in Urban Water cycle

$123,706
Ramesh K Goel · University Of Utah · · FY2020 · ENG

Comprehensive profiling of SARS-CoV-2 antibody responses and escape pathways

$123,360
Julie M Overbaugh · Fred Hutchinson Cancer Center · R01 · FY2022 · AI

Coronavirus Pathogenesis and Broadly Protective Vaccine Development

$123,282
Matthew Memoli · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Administrative Core

$122,848
Amal O Amer · Ohio State University · P01 · FY2024 · AI

Quantitative magnetic resonance imaging of pulmonaryperfusion

$122,788
Iris Yuwen Zhou · Massachusetts General Hospital · R03 · FY2025 · HL

Quantitative magnetic resonance imaging of pulmonaryperfusion

$122,788
Iris Yuwen Zhou · Massachusetts General Hospital · R03 · FY2024 · HL

RAPID: Analyses of polymorphism and divergence to illuminate molecular evolution permissive of zoonoses in SARS and COVID-19

$122,716
Jeffrey P Townsend · Yale University · · FY2020 · BIO

A computational modeling framework for COVID-19 vaccination

$122,580
Jin Wang · University Of Tennessee Chattanooga · R15 · FY2021 · GM

Virtual Reality Augmented Hands-on Cryo-EM Training

$122,453
Yingjie Chen · Purdue University · R25 · FY2023 · EY

Virtual Reality Augmented Hands-on Cryo-EM Training

$122,453
Yingjie Chen · Purdue University · R25 · FY2022 · EY

Virtual Reality Augmented Hands-on Cryo-EM Training

$122,453
Yingjie Chen · Purdue University · R25 · FY2021 · EY

Understanding the immunometabolic response to Klebsiella pneumonia infection

$122,151
Tania Wong Fok Lung · Columbia University Health Sciences · K99 · FY2023 · HL

Understanding the immunometabolic response to Klebsiella pneumonia infection

$122,151
Tania Wong Fok Lung · Columbia University Health Sciences · K99 · FY2022 · HL

Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis

$121,986
Matthew Bryan Frieman · University Of Maryland Baltimore · R01 · FY2016 · AI